Latest Stem cell Stories
Every day trillions of blood cells are being formed in our body: from the oxygen-carrying red blood cells to the many types of white blood cells that fight pathogens and infection.
Celgene Makes Equity Investment in HLI LA JOLLA, Calif., Aug. 11, 2014 /PRNewswire/ -- Human Longevity, Inc.
In a discovery that could improve our general knowledge of biology, lead to more accurate clinical diagnoses and disease monitoring, and serve as a catalyst for new therapies for a variety of conditions, researchers have discovered a way to see through tissues and organs.
The Adult Stem Cell Technology Center, LLC in Boston Massachusetts has more adult stem cell intellectual property than it requires for its own current business development plans.
Medical discoveries continue to reveal the many uses for which stem cell treatment can be used, ranging from kidney disease to brain damage.
COSTA MESA, Calif., July 24, 2014 /PRNewswire/ -- Now available is a stem cell therapy that is incredibly close to home.
The minimally invasive and holistic stem cell therapy brings a new ray of hope for patients suffering from bone degeneration and arthritis conditions. Los Angeles,
Many current regenerative medicine trials are based on heterologous stem cell transplantation, in which stem cells multiplied from one type of organ or tissue are transferred to treat diseases,
Daily Face & Body, a Denver skin care company, is thrilled to release Stem Cell Technology Facial Serum, a safer and cheaper alternative to Botox.
A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...
Cell is a peer-reviewed scientific journal founded by Benjamin Lewin in January 1974 with the sponsorship of MIT Press. Lewin bought the rights to the journal in 1986 and published it under his own publishing arm Cell Press. Cell Press was sold to Elsevier in 1999, which currently publishes Cell twice monthly. Cell Press publishes several biomedical journals, including Cell, Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry &...
More Images (3 images) »